Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Telik Inc (TELK)    
$1.10 0.00 (0.00%) as of 4:30 Tue 9/9


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 4,583,000 as of 6/30
Market Cap: 5.04(M)
Last Volume: 52,147 Avg Vol: 37,187
52 Week Range: $0.7 - $1.7601
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY       NASDAQ COMPOSITE  
    NASDAQ NNM COMPOSITE  

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Telik is a clinical-stage drug development company focused on discovering and developing small molecule drugs to treat cancer. TELINTRA, Co.'s lead drug candidate is a small molecule glutathione analog inhibitor of the enzyme glutathione S-transferase P1-1 (GST P1-1). Co. is developing TELINTRA for the treatment of blood disorders that are characterized by defects in blood formation with associated with low blood cell levels, such as anemia or thrombocytopenia. TELCYTA, Co.'s second product candidate, is a small molecule cancer drug designed to be activated in cancer cells.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 19,500 19,500 19,500 19,500
Total Buy Value $45,640 $45,640 $45,640 $45,640
Total People Bought 3 3 3 3
Total Buy Transactions 4 4 4 4
Total Shares Sold 0 11,892 11,892 11,892
Total Sell Value $0 $71,352 $71,352 $71,352
Total People Sold 0 1 1 1
Total Sell Transactions 0 1 1 1
End Date 2014-09-21 2014-06-20 2013-12-20 2012-12-20

   
Records found: 201
  Page 1 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Cohen Kenneth M Director   –       •      –    2014-12-17 4 B $1.80 $4,500 I/I 2,500 17,616 2.1     -
   Cohen Kenneth M Director   –       •      –    2014-12-16 4 B $2.41 $9,640 I/I 4,000 15,116 2.1     -
   Hoffman Robert Director   –       •      –    2014-12-16 4 B $2.40 $24,000 D/D 10,000 21,116 2.39     -
   Hanson Gregory P Chief Financial Officer   •       –      –    2014-12-16 4 B $2.50 $7,500 D/D 3,000 3,000 2.74     -
   Antonopoulos Jim J. former director   –       –      –    2014-09-12 4 S $6.00 $71,352 D/D (11,892) 21,258     -
   Antonopoulos Jim J. former director   –       –      –    2014-09-12 4 OE $3.62 $120,003 D/D 33,150 33,150     -
   Livingston Philip O. Chief Science OfficerOfficer   •       •      –    2014-07-08 3 IO $0.00 $0 D/D 0 881,181 -21%     
   Livingston Philip O. Chief Science OfficerOfficer   •       •      –    2014-07-08 3 IO $0.00 $0 I/I 0 2,563,123 -21%     
   Hansen John David President and CEOOfficer   •       •      –    2014-07-08 3 IO $0.00 $0 D/D 0 533,589 -21%     
   Scholz Wolfgang W. VP of Antibody DiscoveryOffice   •       –      –    2014-07-08 3 IO $0.00 $0 D/D 0 400,192 -21%     
   Wetherell David S 10% Owner   –       –       •   2014-07-08 3 IO $0.00 $0 I/I 0 3,162,258 -21%     
   Barry Richard 10% Owner   –       –       •   2012-12-17 4 S $1.86 $90,049 D/D (48,390) 243,800 25%     
   Barry Richard 10% Owner   –       –       •   2012-12-13 4 S $2.31 $94,664 D/D (40,920) 292,200 38%     
   Barry Richard 10% Owner   –       –       •   2012-12-12 4 S $1.87 $115,803 D/D (61,798) 292,200 26%     
   Wee Wendy Principal Financial Officer &   •       –      –    2010-12-22 3 IO $0.00 $0 D/D 0 22,273 5%     
   Barry Richard J. 10% Owner   –       –       •   2010-12-13 4 A $0.00 $0 D/D 1,186,055 11,847,125     -
   Cantrall Edward W Director   –       •      –    2010-08-23 4 B $0.72 $4,320 D/D 6,000 50,000 2.31 12%     
   Barry Richard J. 10% Owner   –       –       •   2010-06-24 4 B $0.75 $6,684 D/D 8,912 12,193,779 2.37 7%     
   Barry Richard J. 10% Owner   –       –       •   2010-06-23 4 B $0.75 $7,837 D/D 10,449 12,184,867 2.37 7%     
   Barry Richard J. 10% Owner   –       –       •   2010-06-22 4 B $0.75 $20,312 D/D 27,083 12,174,418 2.37 5%     
   Barry Richard J. 10% Owner   –       –       •   2010-06-21 4 B $0.75 $67,663 D/D 90,217 12,147,335 2.45 8%     
   Barry Richard J. 10% Owner   –       –       •   2010-06-18 4 B $0.76 $40,508 D/D 53,300 12,057,118 2.37 14%     
   Barry Richard J. 10% Owner   –       –       •   2010-06-17 4 B $0.73 $3,212 D/D 4,400 12,003,818 2.37 3%     
   Barry Richard J. 10% Owner   –       –       •   2010-06-15 4/A B $0.76 $76,000 D/D 100,000 11,999,418 2.45     -
   Wick Michael M President, CEO and Chairman   •       •      –    2010-06-15 4 B $0.75 $22,636 D/D 30,000 162,391 2.81 -8%     

  201 Records found
  1  2  3  4  5  6  7  8  9   
  Page 1 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed